A monitor alarms. The rate is 180, the QRS is wide, and the patient is looking at you. You have roughly a minute to decide whether you are watching ventricular tachycardia (VT) or a supraventricular tachycardia (SVT) with aberrant conduction, and in practice you often have to act before you can be certain. This quick reference is built for that minute: what to check first, which ECG clues carry real weight, and which safety principle overrides all of them.
If you want the broader background on wide complex rhythms, our earlier piece on wide complex tachycardia myths and facts covers the concepts, and we will not repeat it here. This article is the provider-level companion: a sequence you can run under pressure, written for clinicians who already know the algorithm and want a faster, cleaner decision path.
The headline is simple. Differentiating VT from SVT with aberrancy is an interesting ECG exercise, but it is never a reason to delay treatment in an unstable patient. When the answer is uncertain, you treat the rhythm as VT. Everything else in this guide supports that principle rather than replacing it.
Current AHA adult advanced life support guidance, summarized in the AHA Part 9 Adult Advanced Life Support guideline, supports synchronized cardioversion for hemodynamically unstable wide-complex tachycardia and allows it for stable patients when drugs are ineffective or contraindicated. The practical teaching that follows is the one every ACLS provider learns: a wide-complex tachycardia is VT until proven otherwise.
The reasoning is asymmetric risk. Treating true VT as SVT can be dangerous, because the drugs and maneuvers aimed at the AV node do nothing for a ventricular circuit and some can make the patient worse. Treating SVT with aberrancy as VT, by contrast, usually costs you little: cardioversion or an antiarrhythmic that covers both mechanisms will typically do the job.
That is why the first branch of your decision is never the ECG. It is the patient.
For the unstable branch, a refresher on technique is worthwhile: our guide to synchronized cardioversion walks through sync mode, sedation, and common errors.
If uncertain wide-complex tachycardia gets treated as VT anyway, why learn to tell them apart? Because in the stable patient, the answer changes your drug choices and your risk profile, and because the exam and megacode reward providers who can explain their reasoning.
The most important example is the calcium channel blocker problem. The 2015 ACC/AHA/HRS guideline for adult supraventricular tachycardia warns that when the QRS is wider than 120 ms, you must distinguish VT from SVT with aberrancy, pre-existing bundle branch block, or pre-excitation, and that verapamil or diltiazem given for VT or pre-excited atrial fibrillation may cause hemodynamic compromise or accelerate the ventricular rate toward ventricular fibrillation. A drug that is routine for narrow-complex SVT can be harmful here.
There are also downstream consequences. A confirmed VT usually points toward structural heart disease, ischemia, or an electrolyte or drug problem that needs work-up. An SVT with aberrancy points toward a different conversation about ablation and rate-related conduction delay. Getting the label right matters for the hours after the first minute.
Before reading a single complex, take ten seconds to confirm a pulse, check blood pressure and mental status, and make sure the rhythm is not a lead artifact. Pseudo-VT from tremor, brushing, or a loose electrode looks alarming on the monitor and is rarely accompanied by a sick patient.
Then use context. The clinical picture shifts your starting probability long before the ECG does:
Context is not proof, but it moves the dial. A regular wide-complex tachycardia in a patient with a scarred ventricle is VT until a specialist proves otherwise.
The ACLS algorithm splits wide-complex tachycardia into regular monomorphic and irregular or polymorphic forms, and your next ten seconds should go to this split. A regular, monomorphic wide-complex rhythm is the classic VT versus SVT-with-aberrancy question. An irregular wide-complex rhythm opens other possibilities: atrial fibrillation with aberrancy, atrial fibrillation with a bypass tract, or polymorphic VT such as torsades de pointes.
Polymorphic VT with a long baseline QT calls for magnesium and correction of the underlying cause, and our overview of recognizing and treating torsades de pointes shows how that pathway differs from monomorphic VT. For the rest of this guide, we focus on the regular, monomorphic case, which is where most differentiation questions arise.
You do not need a full algorithm to get value from the ECG in the first minute. A small set of findings are specific for VT, meaning that when you see them, VT is very likely. Their absence, however, does not exclude VT. That asymmetry is the most commonly misunderstood idea in this topic.
If the atria and ventricles are beating independently, with P waves marching through at their own rate, the ventricle is driving the rhythm. Look in lead II, V1, and any lead where P waves stand out. Visible dissociation is among the most specific findings for VT. At very fast rates, however, P waves are often buried, so failing to find them tells you little.
An occasional narrow beat in the middle of a wide run (a capture beat) or a hybrid beat with a morphology between the normal and tachycardia complexes (a fusion beat) means a sinus impulse is sometimes getting through to compete with a ventricular focus. Both are strong evidence for VT. They are uncommon on a short strip, so do not hunt for them at the expense of the patient.
When every precordial lead from V1 to V6 points the same way, all positive or all negative, the pattern is called concordance. Negative concordance in particular strongly suggests VT, because a supraventricular impulse conducting through the normal His-Purkinje system rarely produces that uniform direction of activation.
A so-called northwest axis, with the QRS strongly negative in leads I and aVF, is unusual in aberrant conduction and favors VT. It is quick to check and requires only the limb leads.
If the tachycardia looks like a textbook right or left bundle branch block, SVT with aberrancy is more plausible. If the shape is atypical for either, with unusual notching, slurring, or a broad initial deflection, VT becomes more likely. This is a softer clue than dissociation or concordance and works best when combined with the clinical context from Step 1.
Several published criteria formalize this scan. You do not need to memorize all of them to work safely, but you should know what the two most cited ones are asking, because exam writers and senior colleagues expect it.
Brugada and colleagues published their stepwise approach to regular wide QRS tachycardia in Circulation in 1991. It is a sequence of questions where a "yes" at any step means VT. As summarized in a peer-reviewed review of wide QRS tachycardia differential diagnosis, the steps are:
Different teaching sources order the steps slightly differently, and some list AV dissociation before the R-to-S interval. What matters is the logic: any positive finding is treated as VT, and the algorithm only reaches "SVT" after every VT feature has been excluded.
Vereckei and colleagues proposed a shorter approach built around a single lead, aVR. The review literature describes the key questions as whether there is an initial R wave in aVR, whether an initial r or q wave is wider than 40 ms, whether there is notching on the descending limb of a predominantly negative QRS, and whether the ventricular activation velocity ratio (Vi/Vt) is 1 or less. Any of those features supports VT.
Its appeal is speed: one lead, a handful of questions. Its limitation is that it still requires careful measurement, and it was designed for monomorphic regular rhythms in patients who are stable enough to look at a printed tracing.
A reappraisal of wide complex tachycardia differentiation in the Journal of the American Heart Association reviews how these methods perform and how newer approaches compare. The consistent lesson across this literature is that no single manual criterion is perfect, performance drops when the rhythm is read quickly by a non-specialist, and the criteria were developed and validated on tracings rather than on crashing patients.
That is exactly why they are a tool for the stable patient. They sharpen your suspicion and guide drug selection when you have time. They are never a license to hold off cardioversion because you "think it might be SVT."
A stable patient with a regular wide-complex tachycardia gives you a short window to be thoughtful. Get a 12-lead ECG, place defibrillation pads, secure IV access, and call for expert consultation if it is available. Treat the situation as potentially unstable, because stability can end suddenly.
Adenosine is a diagnostic and therapeutic tool for narrow-complex SVT, and our SVT treatment decision card lays out the stepwise approach. In the specific case of a regular, monomorphic wide-complex tachycardia, adenosine is sometimes considered in stable patients when the rhythm may be SVT with aberrancy, but only when the rhythm is truly regular and monomorphic, and only with defibrillation capability at the bedside.
It should not be given to irregular wide-complex rhythms, and it is a poor choice when pre-excited atrial fibrillation is possible. If you are not sure the rhythm qualifies, skip the adenosine and use an antiarrhythmic or cardioversion instead. When uncertain, the safe default is always the VT pathway.
Here is the whole approach in sequence. Read it once and you can rebuild it from memory under pressure.
The order is deliberate. The patient comes first, context second, ECG third, and the named criteria are a refinement for the stable patient, not a gate in front of treatment.
Wide-complex tachycardia scenarios are a favorite test of judgment. A typical megacode vignette gives you a regular wide-complex rhythm and a patient whose stability changes partway through the case. The evaluator is usually watching for three things: that you check for a pulse and stability first, that you do not give an AV nodal blocker to an uncertain rhythm, and that you move to synchronized cardioversion promptly when the patient becomes unstable.
To sharpen your recognition, review our ACLS rhythm recognition cheat sheet and the tachycardia algorithm companion on stable versus unstable decisions. Both pair well with this article: the companion covers the algorithm's branching, and this guide zooms in on the wide-complex branch.
When you want to test yourself, the free practice tests are a good way to rehearse rhythm-based questions without pressure. If your certification is coming due and you want an affordable, self-paced option built by practicing emergency physicians, you can review the ACLS certification and recertification course, which is based on current AHA and ILCOR guidelines and lets you retake exams at no extra charge until you pass.
The sixty-second differentiation is really a sixty-second discipline: check the patient, use context, scan for the high-yield clues, and when in doubt, treat the rhythm that can hurt your patient most. Practice it on paper until it becomes automatic, and it will be there when the monitor alarms.
.jpg)
